News
FUJIFILM signs $3B deal with Regeneron for biologics work in Holly Springs
FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO) with major operations in North Carolina, has signed an agreement valued at over $3 billion to produce biologic medicines for Regeneron Pharmaceuticals.
As pharma giants line up one after another to tout their investment plans in the U.S., Regeneron is adopting a different tack ...
Regeneron Pharmaceuticals (NasdaqGS:REGN) announced a major expansion of its manufacturing capacity, including a $3 billion deal with Fujifilm Diosynth Biotechnologies and further investments at its ...
TOKYO -- Fujifilm Holdings announced on Tuesday that it has signed a contract worth more than $3 billion to manufacture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback